two
year
pass
sinc
initi
descript
middl
east
respiratori
syndrom
coronaviru
merscov
yet
epidem
far
control
high
case
fatal
rate
recent
steep
increas
report
case
potenti
caus
global
pandem
upcom
hajj
season
seriou
concern
although
wealth
inform
pathophysiolog
propos
anim
reservoir
intermedi
host
reveal
mani
question
remain
unansw
herein
review
merscov
cover
propos
origin
rout
transmiss
treatment
option
futur
perspect
first
report
middl
east
respiratori
syndrom
coronaviru
merscov
novel
coronaviru
first
lineag
betacoronaviru
known
infect
human
case
fatal
rate
urgent
respons
need
prevent
global
pandem
prior
coronavirus
consid
seriou
human
pathogen
sinc
caus
mild
upper
respiratori
tract
infect
urti
first
zoonot
introduct
coronaviru
human
popul
occur
sever
acut
respiratori
syndrom
coronaviru
sarscov
sarscov
caus
global
pandem
record
case
death
merscov
mark
second
known
zoonot
introduct
highli
pathogen
coronaviru
probabl
origin
bat
three
line
evid
current
support
theori
close
phylogenet
similar
bat
betacoronavirus
close
relat
coronaviru
sequenc
recov
bat
africa
asia
america
eurasia
merscov
use
evolutionari
conserv
dipeptidyl
protein
pipistrellu
pipistrellu
bat
cell
entri
sinc
humanbat
contact
limit
camel
implic
probabl
intermedi
host
merscov
appear
circul
dromedari
camel
year
merscov
use
receptor
gain
entri
effect
replic
camel
cell
line
neutral
antibodi
merscov
detect
dromedari
camel
oman
canari
island
egypt
jordan
unit
arab
emir
saudi
arabia
exact
mode
transmiss
camel
human
remain
confirm
camel
milk
investig
possibl
rout
transmiss
given
common
practic
consum
camel
milk
arabian
peninsula
first
report
case
merscov
yemen
occur
yemeni
pilot
consum
raw
camel
milk
reusken
et
al
report
find
merscov
camel
milk
qatar
howev
respiratori
transmiss
current
consid
like
rout
transmiss
merscov
detect
revers
transcript
pcr
rtpcr
nasal
swab
three
camel
qatar
link
two
confirm
human
case
high
similar
upon
sequenc
suggest
possibl
respiratori
mode
transmiss
sever
cluster
merscov
case
report
mainli
among
household
member
health
care
worker
hcw
suggest
transmiss
close
contact
largest
cluster
report
far
hcw
hospit
al
hasa
kingdom
saudi
arabia
ksa
largest
famili
cluster
three
infect
brother
riyadh
ksa
basic
reproduct
rate
merscov
still
determin
certainti
use
two
transmiss
scenario
breban
et
al
report
cauchemez
et
al
report
similar
warn
absenc
infect
control
measur
may
rang
could
lead
selfsustain
transmiss
propens
merscov
replic
lower
respiratori
tract
may
account
observ
limit
transmiss
unit
state
center
diseas
control
prevent
cdc
recommend
standard
contact
airborn
precaut
use
mask
care
infect
patient
cdc
defin
laboratoryconfirm
case
merscov
patient
posit
pcr
respiratori
sampl
probabl
case
patient
close
contact
confirm
case
inconclus
laboratori
evid
incub
period
present
merscov
symptom
day
remain
unknown
whether
patient
infecti
incub
period
averag
age
present
year
male
predomin
clinic
merscov
caus
symptom
upper
lower
rti
sever
symptom
vari
wide
asymptomat
case
discov
screen
contact
known
case
present
sign
symptom
may
includ
highgrad
fever
nonproduct
cough
dyspnea
headach
myalgia
nausea
vomit
diarrhea
may
preced
respiratori
symptom
renal
failur
frequent
report
yet
conclus
evid
direct
viral
invas
renal
tissu
exist
notabl
patient
develop
complic
coexist
medic
comorbid
laboratori
find
admiss
may
includ
leukopenia
lymphopenia
thrombocytopenia
elev
lactat
dehydrogenas
level
merscov
also
caus
sever
pneumonia
acut
respiratori
distress
syndrom
ard
requir
mechan
ventil
intens
care
admiss
date
still
lack
surgic
patholog
inform
patient
infect
merscov
hamper
full
understand
pathogenesi
lastli
coinfect
respiratori
virus
communityacquir
bacteria
also
report
merscov
patient
june
offici
report
affect
patient
countri
three
contin
twohundr
fiftytwo
patient
die
merscov
set
case
fatal
rate
case
far
acquir
either
directli
probabl
zoonot
sourc
result
transmiss
via
close
contact
retrospect
analysi
track
first
outbreak
hospit
citi
alzarqa
jordan
april
unexplain
observ
season
variat
report
number
peak
april
june
year
number
case
report
april
alon
alarm
greater
cumul
number
case
report
sinc
outbreak
began
recent
increas
number
infect
patient
may
arguabl
attribut
better
case
detect
activ
surveil
program
yet
factor
may
contribut
observ
surg
includ
suboptim
infect
control
practic
affect
hospit
saudi
arabia
document
recent
report
mission
jeddah
anoth
explan
season
variat
may
coincid
camel
birth
season
younger
camel
seem
often
infect
older
counterpart
distribut
total
report
case
countri
follow
ksa
unit
arab
emir
jordan
qatar
case
also
report
kuwait
yemen
oman
iran
lebanon
tunisia
algeria
bangladesh
malaysia
franc
itali
germani
netherland
unit
kingdom
greec
itali
unit
state
furthermor
seroposit
camel
merscov
detect
egypt
kenya
nigeria
tunisia
ethiopia
suggest
may
merscov
case
undetect
africa
muslim
countri
gather
mecca
perform
annual
hajj
largest
gather
muslim
world
identif
merscov
saudi
arabia
gener
intern
concern
global
pandem
respons
saudi
govern
request
elderli
chronic
ill
muslim
avoid
hajj
restrict
number
pilgrim
consequ
case
report
pilgrimag
year
nasopharyng
specimen
collect
pilgrim
reveal
case
merscov
nasal
carriag
prospect
cohort
studi
french
pilgrim
reveal
merscov
case
nevertheless
potenti
spread
merscov
hajj
season
octob
remain
possibl
especi
sinc
document
transmiss
occur
year
patient
iran
malaysia
return
umrah
mecca
worth
note
two
frequent
visit
citi
hajj
mecca
medina
far
report
case
respect
merscov
bind
surfac
receptor
use
spike
surfac
protein
subsequ
cell
entri
exact
mechan
entri
receptor
bind
still
unknown
surfac
protein
compos
core
subdomain
share
similar
sarscov
receptor
bind
subdomain
rbsd
exhibit
signific
variat
sarscov
rbsd
develop
vaccin
target
rbsd
merscov
current
investig
thought
safer
effect
vaccin
base
inactiv
viru
dna
viral
vector
anoth
potenti
therapeut
approach
inhibit
papainlik
andor
proteas
merscov
date
effect
therapi
prophylaxi
merscov
exist
support
therapi
remain
cornerston
manag
current
treatment
base
previou
experi
sarscov
invitro
studi
case
seri
variou
agent
tri
includ
block
viru
entri
inhibit
viral
replic
interfer
host
immun
respons
intern
sever
acut
respiratori
emerg
infect
consortium
isar
suggest
therapeut
option
treatment
merscov
infect
variou
agent
alongsid
continu
evalu
efficaci
set
clinic
trial
base
experi
sarscov
use
convalesc
plasma
hyperimmun
globulin
human
monoclon
antibodi
contain
neutral
antibodi
may
efficaci
recommend
firstlin
treatment
avail
ribavirin
interferon
show
promis
result
especi
use
combin
vitro
anim
studi
use
rhesu
macaqu
monkey
howev
posit
result
translat
clinic
observ
studi
five
patient
succumb
infect
repurpos
current
avail
agent
may
effici
approach
dyall
et
al
screen
variou
agent
potenti
therapeut
efficaci
cyclosporin
mycophenol
acid
interferonbeta
homoharringtonin
cycloheximid
anisomycin
emetin
dihydrochlorid
hydrat
found
potent
vitro
activ
merscov
despit
progress
understand
merscov
mani
question
remain
unansw
definit
origin
exact
mechan
transmiss
reason
behind
season
variabl
still
unclear
although
case
describ
countri
arabian
peninsula
increas
travel
region
hajj
season
ksa
pose
threat
potenti
global
pandem
extens
effort
requir
speed
develop
effect
therapi
vaccin
repurpos
current
avail
pharmaceut
agent
highli
desir
rapid
drug
develop
meanwhil
hcw
encount
patient
respiratori
symptom
live
travel
area
merscov
low
threshold
consid
diagnosi
merscov
test
immedi
implement
proper
infect
control
practic
prevent
spread
final
given
import
role
camel
may
play
transmiss
viru
common
practic
arabian
peninsula
herd
consum
unpasteur
camel
milk
discourag
conclus
evid
obtain
practic
contribut
infect
